Clinical Trial Update: PET and MRI Imaging of Brain Tumors Using [18F]PARPi [EARLY_Phase 1]

View source ↗

Summary

An early-phase imaging trial used [18F]PARPi for PET/MRI imaging of brain tumors. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Tumor

Drugs mentioned

• [18F]PARPi (Fluorine-18 labeled PARP inhibitor radiotracer)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Tumor, Brain Cancer | EARLY_Phase 1 | Status: COMPLETED